Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong National Union Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of generic drug products. Founded in 1994 and based in Shantou, the company operates modern, GMP-certified facilities for the production of various oral dosage forms, including tablets and capsules. Its product portfolio is diverse, with a strong focus on anti-infectives, cardiovascular medications, and treatments for metabolic disorders. Key products include widely used agents such as amlodipine, metformin, and several cephalosporin antibiotics. National Union Pharmaceutical primarily serves the domestic Chinese market, aiming to provide high-quality and cost-effective therapeutic options. The company maintains a robust quality management system to ensure compliance with national regulatory standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Union.